Compare Citra Tubindo Tbk. (CTBN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citra Tubindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Citra Tubindo Tbk. trades at Rp4,990 (market cap 4.04T, 44.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 51K 24h volume). The key difference: Citra Tubindo Tbk. is far larger — about 24.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (51K versus 44.2K). Which is the better fit depends on your goals.
| CTBN | OBAT | |
|---|---|---|
Market Cap | 4.04T | 167.37B |
Volume | 44.2K | 51K |
Lot | 442 | 510 |
Turnover | 220.93M | 12.55M |
Average Price | 4,998.35 | 246.09 |
Value | 220.93M | 12.55M |
Indicative Equilibrium Price | 5,000 | 246 |
Indicative Equilibrium Volume | 2 | 2.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citra Tubindo Tbk.
PT Citra Tubindo Tbk (the Company) was established on August 23rd, 1983, on Batam Island under the rules of the Domestic Capital Investment (PMDN) the main activities of the Company are seamless pipe processing, end finishing of Oil Country Tubular Goods (OCTG) and fabricating accessories for the Oil and Gas Industry. The Threading and End Finishing plant commenced commercial operation in 1984 and received American Petroleum Institute (API) in the same year. In 1986 the Company installed and put into operation a precision electro-plating plant which also passed the stringent requirements of MEPSI (Mobil Exploration and Production Services Inc.) standards. The Company has also built an assembly line for Drilltec Protectors, to reduce the dependency on overseas supplies. The products of the Company are distributed among domestic and international oil and gas contractors operating in Indonesia, and increasingly exported to contractors working in countries such as Malaysia, India, Vietnam, the Middle East, Japan Canada, Australia, Venezuela and the Philippines.
Read more on CTBN →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
